Skip to main content

Hernia Mesh Cases Can be Filed Directly Under Federal MDL

Hernia Mesh Cases Can be Filed Directly Under Federal MDL

Hernia Mesh Cases Can be Filed Directly Under Federal MDL

Introduction

As per an order submitted on September 7, hernia mesh lawsuits involving C.R. Bard Inc 's polypropylene implants can be filed directly in the multidistrict litigation which is underway in the U.S. District Court, Southern District of Ohio. The direct filing would eliminate delays in transferring the cases from other jurisdiction. Also, it would promote judicial efficiency and facilitate coordinated discovery and other pretrial proceedings. Any case remaining unresolved would be remanded back to appropriate jurisdiction and venue for trial by the Court.

There are more than 170 hernia mesh lawsuits pending in the federal MDL filed by individuals who suffered serious injuries allegedly due to the defective polypropylene hernia mesh implants. Ventralex, Perfix, and Composix devices sold by C.R. Bard and its Davol, Inc. subsidiary have been reported to be defectively designed in the lawsuits.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!